“Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms”. Link Medical Journal, vol. 3, no. 2, Dec. 2025, p. e76, https://doi.org/10.61919/gsj6hy59.